ELDN — Eledon Pharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapMomentum Trap

Annual balance sheet for Eledon Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	84.8	56.4	51.1	140	133
Net Total Receivables	0	—	—	—	0.514
Prepaid Expenses
Total Other Current Assets
Total Current Assets	88.3	59.5	56.1	144	136
Net Property, Plant And Equipment	0.768	0.739	0.365	0.926	0.613
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	171	92.8	89.1	177	169
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	4.4	6.47	3.9	11.6	18.3
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	6.55	8.61	5.65	59.3	32.2
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	164	84.2	83.4	118	137
Total Liabilities & Shareholders' Equity	171	92.8	89.1	177	169
Total Common Shares Outstanding
Total Preferred Shares Outstanding